[Differential approaches to intensive care of patients with severe acute porphyria].
Pustovoĭt
Ia S
IaS
Iatskov
K V
KV
Karpova
I V
IV
Shulutko
E M
EM
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001120:Arginine / Q000008:administration & dosage / Q000627:therapeutic use; D003422:Critical Care / Q000379:methods*; D004750:Enteral Nutrition; D006418:Heme / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D010289:Parenteral Nutrition, Total; D017118:Porphyria, Acute Intermittent / Q000097:blood / Q000150:complications* / Q000628:therapy*; D011166:Porphyrins / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D012121:Respiration, Artificial; D012720:Severity of Illness Index; D013577:Syndrome
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000959:Antihypertensive Agents; D011166:Porphyrins; D006418:Heme; D001120:Arginine; C048849:heme arginate